IDPN-2
- Conditions
- Chronic kidney diseaseChronic kidney disease, dialysis, malnutrition
- Registration Number
- JPRN-jRCTs031220296
- Lead Sponsor
- Kanno Yoshihiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Malnourished maintenance hemodialysis patients with inadequate oral intake
(1)Patients aged 20 years or older at the time of informed consent
(2)Patients with a nutritional risk index for Japanese hemodialysis patients (NRI-JH) of 5 to 10 within 2 months prior to the start of the study
(3)Patients who can obtain informed consent from themselves (Patients who can obtain informed consent from themselves and their regal representatives if their capacity to give informed consent is found to decline)
(1)Patients who received maintenance hemodialysis for less than 6 months
(2)Patients who are contraindicated to receive ENEFLUID Injection
(3)Patients who received IDPN within 1 month
(4)Patients who are pregnant or wish to become pregnant
(5)Patients with type 1 diabetes
(6)Patients with severe infection
(7)Patients who have been diagnosed and treated for malignant tumors within the past 3 years (excluding basal cell carcinoma of the skin or carcinoma in the uterine cervix which was surgically resected)
(8)Patients who with amputation of the lower limbs
(9)Patients who deemed ineligible for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method